pgl 3- basic vector (Promega)
Structured Review
Pgl 3 Basic Vector, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pgl+3-+basic+vector/pgl3+basic/pm38360124-80-27-31
Average 90 stars, based on 1 article reviews
Images
Related Articles
Activity Assay:Article Title: The METTL3-m 6 A-YTHDC1-AMIGO2 axis contributes to cell proliferation and migration in esophageal squamous cell carcinoma. Article Snippet: The upregulation of methyltransferase-like 3 (METTL3) has been associated with the progression of esophageal cancer.. However, METTL3-induced N6-methyladenosine (m6A) alterations on the downstream target mRNAs in esophageal squamous cell carcinoma (ESCC) are not yet fully understood.. Our study revealed that silencing METTL3 resulted in a significant decrease in ESCC cell proliferation and metastasis in vitro and in vivo. Construct:Article Title: The METTL3-m 6 A-YTHDC1-AMIGO2 axis contributes to cell proliferation and migration in esophageal squamous cell carcinoma. Article Snippet: The upregulation of methyltransferase-like 3 (METTL3) has been associated with the progression of esophageal cancer.. However, METTL3-induced N6-methyladenosine (m6A) alterations on the downstream target mRNAs in esophageal squamous cell carcinoma (ESCC) are not yet fully understood.. Our study revealed that silencing METTL3 resulted in a significant decrease in ESCC cell proliferation and metastasis in vitro and in vivo. Clone Assay:Article Title: The METTL3-m 6 A-YTHDC1-AMIGO2 axis contributes to cell proliferation and migration in esophageal squamous cell carcinoma. Article Snippet: The upregulation of methyltransferase-like 3 (METTL3) has been associated with the progression of esophageal cancer.. However, METTL3-induced N6-methyladenosine (m6A) alterations on the downstream target mRNAs in esophageal squamous cell carcinoma (ESCC) are not yet fully understood.. Our study revealed that silencing METTL3 resulted in a significant decrease in ESCC cell proliferation and metastasis in vitro and in vivo. Synthesized:Article Title: The METTL3-m 6 A-YTHDC1-AMIGO2 axis contributes to cell proliferation and migration in esophageal squamous cell carcinoma. Article Snippet: The upregulation of methyltransferase-like 3 (METTL3) has been associated with the progression of esophageal cancer.. However, METTL3-induced N6-methyladenosine (m6A) alterations on the downstream target mRNAs in esophageal squamous cell carcinoma (ESCC) are not yet fully understood.. Our study revealed that silencing METTL3 resulted in a significant decrease in ESCC cell proliferation and metastasis in vitro and in vivo. Plasmid Preparation:Article Title: The METTL3-m 6 A-YTHDC1-AMIGO2 axis contributes to cell proliferation and migration in esophageal squamous cell carcinoma. Article Snippet: The upregulation of methyltransferase-like 3 (METTL3) has been associated with the progression of esophageal cancer.. However, METTL3-induced N6-methyladenosine (m6A) alterations on the downstream target mRNAs in esophageal squamous cell carcinoma (ESCC) are not yet fully understood.. Our study revealed that silencing METTL3 resulted in a significant decrease in ESCC cell proliferation and metastasis in vitro and in vivo. |
